Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?

Treatments for central nervous system diseases with therapeutic antibodies have been increasingly investigated over the last decades, leading to some approved monoclonal antibodies for brain disease therapies. The detection of biomarkers for diagnosis purposes with non-invasive antibody-based imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsitokana, Mireille Elodie, Lafon, Pierre-André, Prézeau, Laurent, Pin, Jean-Philippe, Rondard, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916958/
https://www.ncbi.nlm.nih.gov/pubmed/36768953
http://dx.doi.org/10.3390/ijms24032632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916958/
https://www.ncbi.nlm.nih.gov/pubmed/36768953
http://dx.doi.org/10.3390/ijms24032632

Ejemplares similares